Literature DB >> 9549747

Sevoflurane for controlled hypotension during spinal surgery: preliminary experience in five adolescents.

J D Tobias1.   

Abstract

The physical properties of sevoflurane suggest that it may be a suitable agent for controlled hypotension. With its low blood:gas partition coefficient of 0.69, it has a rapid onset of action making it easy to rapidly control blood pressure. The current report outlines preliminary experience with sevoflurane for controlled hypotension during posterior spinal fusion in five adolescents. The patients ranged in age from 12 to 16 years and in weight from 49 to to 72kg. The duration of controlled hypotension varied from two to three h. The expired sevoflurane concentration required to maintain the mean arterial pressure (MAP) at 55 to 65 mmHg varied from 2 to 4%. With sevoflurane, there was an increase in heart rate from baseline of 74 +/- 7 beats.min-1 to a maximum of 83 +/- 13 beats.min-1 (P = 0.038). One patient required three intravenous doses of esmolol (10mg each) for a heart rate in excess of 100 beats.min-1. Estimated blood loss varied from 300 to 850 ml. No patient received homologous blood. No excessive hypotension was noted with sevoflurane. No patient required calcium, alpha adrenergic agonists, or ephedrine for excessive hypotension. When controlled hypotension was no longer necessary, the sevoflurane concentration was decreased to 1%. After decreasing the sevoflurane to 1%, the time to return of the MAP to baseline varied from 4 to 8 min (5.6 +/- 1.8 min).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9549747     DOI: 10.1046/j.1460-9592.1998.00700.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  5 in total

1.  A prospective, open-label trial of clevidipine for controlled hypotension during posterior spinal fusion.

Authors:  Hiromi Kako; Andrew Gable; David Martin; Allan Beebe; Arlyne Thung; Walter Samora; Jan Klamar; Tarun Bhalla; Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jan-Feb

Review 2.  Controlled hypotension: a guide to drug choice.

Authors:  Christian-Serge Degoute
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Controlled hypotension in children: a critical review of available agents.

Authors:  Joseph D Tobias
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients.

Authors:  Gregory B Hammer; Susan T Verghese; David R Drover; Myron Yaster; Joseph R Tobin
Journal:  BMC Anesthesiol       Date:  2008-10-06       Impact factor: 2.217

5.  Evaluation of sodium nitroprusside for controlled hypotension in children during surgery.

Authors:  David R Drover; Gregory B Hammer; Jeffrey S Barrett; Carol A Cohane; Tammy Reece; Anne Zajicek; Scott R Schulman
Journal:  Front Pharmacol       Date:  2015-07-06       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.